PGF and preeclampsia: Integration of this biomarker into routine prenatal care may enhance early detection and management of preeclampsia, head-to-head comparisons with sFlt-1/PlGF in diverse populations, and cost-effectiveness analyses to assess clinical utility in routine obstetric care.